S
6955
vs
PNEXF
S
6955
PNEXF
Over the past 12 months, Shandong Boan Biotechnology Co Ltd has outperformed PNEXF, delivering a return of -15% compared to the PNEXF's 0% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
6955
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Shandong Boan Biotechnology Co Ltd Intrinsic Value
LOCKED
PNEXF Intrinsic Value
LOCKED
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
7.07
HKD
|
|||||
|
Pharnext SCA
OTC:PNEXF
|
999 999.9999
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
6955, PNEXF
6955, PNEXF
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Shandong Boan Biotechnology Co Ltd
Revenue
|
|||||||||||
|
|
Pharnext SCA
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6955, PNEXF
6955, PNEXF
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
|||||||||
|
|
Pharnext SCA
OTC:PNEXF
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Shandong Boan Biotechnology Co Ltd
71.7%
PNEXF
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
Operating Margin
Shandong Boan Biotechnology Co Ltd
9.5%
PNEXF
-17 526.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
Net Margin
Shandong Boan Biotechnology Co Ltd
4.2%
PNEXF
-21 040%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
FCF Margin
Shandong Boan Biotechnology Co Ltd
-24.5%
PNEXF
-15 953.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
ROE
Shandong Boan Biotechnology Co Ltd
1.9%
PNEXF
114.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
ROA
Shandong Boan Biotechnology Co Ltd
1.1%
PNEXF
-391.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
ROIC
Shandong Boan Biotechnology Co Ltd
3%
PNEXF
3 092.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
ROCE
Shandong Boan Biotechnology Co Ltd
3.2%
PNEXF
275.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Pharnext SCA | ||||
Solvency Comparison
S
Shandong Boan Biotechnology Co L...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
6955, PNEXF
6955, PNEXF
Performance Gap
6955, PNEXF
6955, PNEXF
Performance Gap Between 6955 and PNEXF
LOCKED
Performance By Year
6955, PNEXF
6955, PNEXF
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 6955 to other stocks
ABBV
Abbvie Inc
More expensive
vs Shandong Boan Biotechnology Co...
AMGN
Amgen Inc
More expensive
vs Shandong Boan Biotechnology Co...
GILD
Gilead Sciences Inc
More expensive
vs Shandong Boan Biotechnology Co...
VRTX
Vertex Pharmaceuticals Inc
More expensive
vs Shandong Boan Biotechnology Co...
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
